» Articles » PMID: 7615725

PCR Amplicon Restriction Endonuclease Analysis of the Chromosomal Dhps Gene of Neisseria Meningitidis: a Method for Studying Spread of the Disease-causing Strain in Contacts of Patients with Meningococcal Disease

Overview
Specialty Microbiology
Date 1995 May 1
PMID 7615725
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

We tested two sets of primers derived from the dhps gene of Neisseria meningitidis for the amplification of meningococcal DNA by PCR. Both the NM1-NM6 primers and the NM3-NM6 primers amplified dhps DNA from all of the meningococci included in the study, resulting, in most cases, in amplicons of 0.70 and 0.23 kb, respectively. Also, dhps DNAs of N. gonorrhoeae and some commensals were amplified but Haemophilus influenzae, Streptococcus pneumoniae, and Escherichia coli DNAs were not. By PCR amplicon restriction endonuclease analysis (AREA) of the larger amplicon, we could differentiate between individual strains of N. meningitidis. Following two cases of meningococcal disease, we used PCR AREA to identify healthy contacts carrying the disease-causing strain. We conclude that PCR AREA is a useful method for meningococcal strain differentiation and that it has potential as a method for studying the spread of a disease-causing strain in an affected population. The method is quicker and easier to perform and interpret than chromosomal DNA fingerprinting.

Citing Articles

Variations in gene organization and DNA uptake signal sequence in the folP region between commensal and pathogenic Neisseria species.

Qvarnstrom Y, Swedberg G BMC Microbiol. 2006; 6:11.

PMID: 16503987 PMC: 1431543. DOI: 10.1186/1471-2180-6-11.


Interlaboratory comparison of PCR-based methods for detection of penicillin G susceptibility in Neisseria meningitidis.

Taha M, Zarantonelli M, Neri A, Enriquez R, Vazquez J, Stefanelli P Antimicrob Agents Chemother. 2006; 50(3):887-92.

PMID: 16495247 PMC: 1426420. DOI: 10.1128/AAC.50.3.887-892.2006.


PCR and restriction endonuclease assay for detection of a novel mutation associated with sulfonamide resistance in Neisseria meningitidis.

Bennett D, Cafferkey M Antimicrob Agents Chemother. 2003; 47(10):3336-8.

PMID: 14506052 PMC: 201121. DOI: 10.1128/AAC.47.10.3336-3338.2003.


One-step heminested PCR for amplification of Neisseria meningitidis DNA in cerebrospinal fluid.

Atobe J, Hirata M, Hoshino-Shimizu S, Schmal M, Mamizuka E J Clin Lab Anal. 2000; 14(4):193-9.

PMID: 10906773 PMC: 6807792. DOI: 10.1002/1098-2825(2000)14:4<193::aid-jcla9>3.0.co;2-2.


Which contacts of patients with meningococcal disease carry the pathogenic strain of Neisseria meningitidis? A population based study.

Kristiansen B, Tveten Y, Jenkins A BMJ. 1998; 317(7159):621-5.

PMID: 9727987 PMC: 28653. DOI: 10.1136/bmj.317.7159.621.


References
1.
Ni H, Knight A, Cartwright K, Palmer W, McFadden J . Polymerase chain reaction for diagnosis of meningococcal meningitis. Lancet. 1992; 340(8833):1432-4. DOI: 10.1016/0140-6736(92)92622-m. View

2.
BOVRE K, Froholm L, Gaustad P, Holten E, Hoiby E . Some agent characteristics and their coexistence related to occurrence and severity of systemic meningococcal disease in Norway, Winter 1981-1982. NIPH Ann. 1983; 6(1):75-84. View

3.
Froholm L, BOVRE K, Holten E, Zollinger W . Serotyping of meningococci by coagglutination with monoclonal antibodies. NIPH Ann. 1983; 6(2):125-31. View

4.
Caugant D, Kristiansen B, Froholm L, BOVRE K, Selander R . Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers. Infect Immun. 1988; 56(8):2060-8. PMC: 259523. DOI: 10.1128/iai.56.8.2060-2068.1988. View

5.
Kristiansen B, Lind K, Mevold K, Sorensen B, Froholm L, Bryn K . Meningococcal phenotypic and genotypic characteristics and human antibody levels. J Clin Microbiol. 1988; 26(10):1988-92. PMC: 266803. DOI: 10.1128/jcm.26.10.1988-1992.1988. View